Levetiracetam Injection, Solution
Product Images NDC 55150-246

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 55150-246). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1: Responder Rate (≥50% Reduction From Baseline) In Study 1 (Levetiracetam Fig1)

Figure 1: Responder Rate (≥50% Reduction From Baseline) In Study 1 (Levetiracetam Fig1)
A bar graph comparing the percentage of patients among three groups: placebo, Levetiracetam 1,000 mg/day, and Levetiracetam 3,000 mg/day. The y-axis represents the percentage of patients, with values approximately 7.4% for placebo, 37.1% for 1,000 mg/day Levetiracetam, and 39.6% for 3,000 mg/day Levetiracetam. Asterisks indicate statistical significance versus placebo.*
FDA Label Image

Package Label-principal Display Panel (1,000 mg per 100 mL (10 mg / mL))

Package Label-principal Display Panel (1,000 mg per 100 mL (10 mg / mL))
Levetiracetam 1000 mg per 100 mL (10 mg/mL) in 0.75% Sodium Chloride Injection label for intravenous infusion. The label indicates single-dose 100 mL bags, with packaging of 10 bags, distributed by AuroMedics Pharma LLC and made in India. Usage and storage instructions, including infusion period and caution notes, are included on the label.*
FDA Label Image

Package Label-principal Display Panel (1,500 mg per 100 mL (15 mg / mL))

Package Label-principal Display Panel (1,500 mg per 100 mL (15 mg / mL))
Levetiracetam 1500 mg per 100 mL injection, solution in 0.54% sodium chloride for intravenous infusion. The label details infusion instructions, contents per 100 mL, storage recommendations, cautions, and manufacturing information by AuroMedics Pharma LLC for Eugia US LLC. The vial size is 100 mL.*
FDA Label Image

Package Label-principal Display Panel (1,500 mg per 100 mL (15 mg / mL))

Package Label-principal Display Panel (1,500 mg per 100 mL (15 mg / mL))
Label for Levetiracetam in 0.54% Sodium Chloride Injection 1500 mg per 100 mL (15 mg/mL) intravenous infusion solution. The single-dose dual port bag contains 100 mL. Distributed by AuroMedics Pharma LLC and made in India. The label includes usage instructions, storage recommendations, and cautions against plastic containers in series connections.*
FDA Label Image

Package Label-principal Display Panel (1,500 mg per 100 mL (15 mg / mL))

Package Label-principal Display Panel (1,500 mg per 100 mL (15 mg / mL))
Levetiracetam injection label for 1500 mg per 100 mL (15 mg/mL) in 0.54% sodium chloride solution. The label specifies intravenous infusion use and single-dose 100 mL bags in packs of 10. Distributed by AuroMedics Pharma LLC. Instructions for infusion and storage are included along with regulatory and packaging details.*
FDA Label Image

Figure 2: Responder Rate (≥50% Reduction From Baseline) In Study 2: Period A (Levetiracetam Fig2)

Figure 2: Responder Rate (≥50% Reduction From Baseline) In Study 2: Period A (Levetiracetam Fig2)
A bar chart displaying the percentage of patients in three groups: Placebo (6.3%), Levetiracetam 1,000 mg/day (20.8%), and Levetiracetam 2,000 mg/day (35.2%). The chart indicates statistical significance versus placebo for the Levetiracetam groups.*
FDA Label Image

Figure 3: Responder Rate (≥50% Reduction From Baseline) In Study 3 (Levetiracetam Fig3)

Figure 3: Responder Rate (≥50% Reduction From Baseline) In Study 3 (Levetiracetam Fig3)
Bar chart comparing the percentage of patients for Placebo and Levetiracetam 3,000 mg/day groups. The placebo group (N=104) shows about 14.4% of patients, while the Levetiracetam group (N=180) shows about 39.4% of patients, with a noted statistically significant difference indicated by an asterisk.*
FDA Label Image

Figure 4: Responder Rate (≥50% Reduction From Baseline) In Pgtc Seizure Frequency Per Week (Levetiracetam Fig4)

Figure 4: Responder Rate (≥50% Reduction From Baseline) In Pgtc Seizure Frequency Per Week (Levetiracetam Fig4)
A bar chart comparing the percentage of patients between placebo and Levetiracetam groups. The placebo group (N=84) shows 45.2% of patients, while the Levetiracetam group (N=79) shows 72.2%, with a notation indicating statistical significance versus placebo.*
FDA Label Image

Package Label-principal Display Panel (500 mg per 100 mL (5 mg / mL))

Package Label-principal Display Panel (500 mg per 100 mL (5 mg / mL))
Label for Levetiracetam 500 mg per 100 mL injection solution in 0.82% sodium chloride for intravenous infusion. The label specifies a 100 mL volume and includes usage instructions, storage conditions at 20° to 25°C, and manufacturer details for AuroMedics Pharma LLC. It also features regulatory information such as NDC 55150-246-47 and caution statements regarding infusion use.*
FDA Label Image

Package Label-principal Display Panel (500 mg per 100 mL (5 mg / mL))

Package Label-principal Display Panel (500 mg per 100 mL (5 mg / mL))
Label for Levetiracetam in 0.82% Sodium Chloride Injection, 500 mg per 100 mL (5 mg/mL) intravenous solution. The label indicates it is for intravenous infusion only, with instructions to tear at the notch to open. Distributed by AuroMedics Pharma LLC and made in India. Contains storage and usage cautions, along with barcode and regulatory symbols.*
FDA Label Image

Package Label-principal Display Panel (500 mg per 100 mL (5 mg / mL))

Package Label-principal Display Panel (500 mg per 100 mL (5 mg / mL))
Levetiracetam 500 mg per 100 mL (5 mg/mL) in 0.82% sodium chloride injection for intravenous infusion only. The label states it is a 10 x 100 mL single-dose bag pack. Distributed by AuroMedics Pharma LLC. The label includes usage instructions, storage recommendations, and cautionary information.*
FDA Label Image

Package Label-principal Display Panel (1,000 mg per 100 mL (10 mg / mL))

Package Label-principal Display Panel (1,000 mg per 100 mL (10 mg / mL))
Levetiracetam 1000 mg per 100 mL injection, solution for intravenous infusion. Label indicates 1,000 mg levetiracetam in 0.75% sodium chloride, with detailed usage instructions, storage conditions, and manufacturer as AuroMedics Pharma LLC. Container size is 100 mL with NDC 55150-247-47.*
FDA Label Image

Package Label-principal Display Panel (1,000 mg per 100 mL (10 mg / mL))

Package Label-principal Display Panel (1,000 mg per 100 mL (10 mg / mL))
Label for Levetiracetam in 0.75% Sodium Chloride Injection, 1000 mg per 100 mL (10 mg/mL) solution for intravenous infusion. The label includes detailed product information such as administration instructions, contents per 100 mL, cautionary notes, and storage conditions. It is distributed by AuroMedics Pharma LLC and manufactured in India.*
FDA Label Image

Levetiracetam Chemical Structure (Levetiracetam Str)

Levetiracetam Chemical Structure (Levetiracetam Str)
Chemical structure of levetiracetam, depicting the molecular arrangement of atoms including a pyrrolidone ring and side groups consistent with its known chemical formula.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.